ClinicalTrials.gov
public full text
Public Domain
Elocon vs Fluticasone in Localized Psoriasis (P03197)
This is an open-label, randomized, parallel-group clinical study. The primary objective is to assess the difference in response rate between mometasone furoate cream 0.1% (once daily) vs fluticasone propionate cream 0.05% (twice daily) by the end of Day 4 and Day 8 in the management of Indian patients with localized psoriasis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis#1321394
- Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment#1114460
- Moderate to Severe Plaque Psoriasis With Scalp Involvement#864332
- Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis#879089
- Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot#872131
Record · ID 1362512
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive